0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Medications for Canine Atopic Dermatitis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-13T13744
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Medications for Canine Atopic Dermatitis Market Research Report 2023
BUY CHAPTERS

Medications for Canine Atopic Dermatitis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13T13744
Report
November 2024
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medications for Canine Atopic Dermatitis - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Medications for Canine Atopic Dermatitis - Market

Medications for Canine Atopic Dermatitis - Market

The global market for Medications for Canine Atopic Dermatitis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medications for Canine Atopic Dermatitis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medications for Canine Atopic Dermatitis by region & country, by Type, and by Application.
The Medications for Canine Atopic Dermatitis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medications for Canine Atopic Dermatitis.
Market Segmentation

Scope of Medications for Canine Atopic Dermatitis - Market Report

Report Metric Details
Report Name Medications for Canine Atopic Dermatitis - Market
CAGR 5%
Segment by Type:
  • Oral
  • External Use
  • Injection
Segment by Application
  • Veterinary Hospital
  • Veterinary Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlenHaven, DermaPet, DVM Pharmaceuticals, Virbac, Enzo Life Sciences, Inc., Pfizer Animal Health, Novartis Animal Health, Inc., Eli Lilly and Company, Perrigo, Merck & Company, Zoetis Inc., Toray Industries, Inc, Bayer Animal Health, Putney, Inc., Dechra, Elanco, Kindred Biosciences, Nippon Zenyaku Kogyo Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Medications for Canine Atopic Dermatitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Medications for Canine Atopic Dermatitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Medications for Canine Atopic Dermatitis in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Medications for Canine Atopic Dermatitis - Market report?

Ans: The main players in the Medications for Canine Atopic Dermatitis - Market are GlenHaven, DermaPet, DVM Pharmaceuticals, Virbac, Enzo Life Sciences, Inc., Pfizer Animal Health, Novartis Animal Health, Inc., Eli Lilly and Company, Perrigo, Merck & Company, Zoetis Inc., Toray Industries, Inc, Bayer Animal Health, Putney, Inc., Dechra, Elanco, Kindred Biosciences, Nippon Zenyaku Kogyo Co., Ltd.

What are the Application segmentation covered in the Medications for Canine Atopic Dermatitis - Market report?

Ans: The Applications covered in the Medications for Canine Atopic Dermatitis - Market report are Veterinary Hospital, Veterinary Clinic

What are the Type segmentation covered in the Medications for Canine Atopic Dermatitis - Market report?

Ans: The Types covered in the Medications for Canine Atopic Dermatitis - Market report are Oral, External Use, Injection

1 Market Overview
1.1 Medications for Canine Atopic Dermatitis Product Introduction
1.2 Global Medications for Canine Atopic Dermatitis Market Size Forecast
1.2.1 Global Medications for Canine Atopic Dermatitis Sales Value (2019-2030)
1.2.2 Global Medications for Canine Atopic Dermatitis Sales Volume (2019-2030)
1.2.3 Global Medications for Canine Atopic Dermatitis Sales Price (2019-2030)
1.3 Medications for Canine Atopic Dermatitis Market Trends & Drivers
1.3.1 Medications for Canine Atopic Dermatitis Industry Trends
1.3.2 Medications for Canine Atopic Dermatitis Market Drivers & Opportunity
1.3.3 Medications for Canine Atopic Dermatitis Market Challenges
1.3.4 Medications for Canine Atopic Dermatitis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medications for Canine Atopic Dermatitis Players Revenue Ranking (2023)
2.2 Global Medications for Canine Atopic Dermatitis Revenue by Company (2019-2024)
2.3 Global Medications for Canine Atopic Dermatitis Players Sales Volume Ranking (2023)
2.4 Global Medications for Canine Atopic Dermatitis Sales Volume by Company Players (2019-2024)
2.5 Global Medications for Canine Atopic Dermatitis Average Price by Company (2019-2024)
2.6 Key Manufacturers Medications for Canine Atopic Dermatitis Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Medications for Canine Atopic Dermatitis Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Medications for Canine Atopic Dermatitis
2.9 Medications for Canine Atopic Dermatitis Market Competitive Analysis
2.9.1 Medications for Canine Atopic Dermatitis Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Medications for Canine Atopic Dermatitis Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Canine Atopic Dermatitis as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 External Use
3.1.3 Injection
3.2 Global Medications for Canine Atopic Dermatitis Sales Value by Type
3.2.1 Global Medications for Canine Atopic Dermatitis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Medications for Canine Atopic Dermatitis Sales Value, by Type (2019-2030)
3.2.3 Global Medications for Canine Atopic Dermatitis Sales Value, by Type (%) (2019-2030)
3.3 Global Medications for Canine Atopic Dermatitis Sales Volume by Type
3.3.1 Global Medications for Canine Atopic Dermatitis Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Medications for Canine Atopic Dermatitis Sales Volume, by Type (2019-2030)
3.3.3 Global Medications for Canine Atopic Dermatitis Sales Volume, by Type (%) (2019-2030)
3.4 Global Medications for Canine Atopic Dermatitis Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Veterinary Hospital
4.1.2 Veterinary Clinic
4.2 Global Medications for Canine Atopic Dermatitis Sales Value by Application
4.2.1 Global Medications for Canine Atopic Dermatitis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Medications for Canine Atopic Dermatitis Sales Value, by Application (2019-2030)
4.2.3 Global Medications for Canine Atopic Dermatitis Sales Value, by Application (%) (2019-2030)
4.3 Global Medications for Canine Atopic Dermatitis Sales Volume by Application
4.3.1 Global Medications for Canine Atopic Dermatitis Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Medications for Canine Atopic Dermatitis Sales Volume, by Application (2019-2030)
4.3.3 Global Medications for Canine Atopic Dermatitis Sales Volume, by Application (%) (2019-2030)
4.4 Global Medications for Canine Atopic Dermatitis Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Medications for Canine Atopic Dermatitis Sales Value by Region
5.1.1 Global Medications for Canine Atopic Dermatitis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Medications for Canine Atopic Dermatitis Sales Value by Region (2019-2024)
5.1.3 Global Medications for Canine Atopic Dermatitis Sales Value by Region (2025-2030)
5.1.4 Global Medications for Canine Atopic Dermatitis Sales Value by Region (%), (2019-2030)
5.2 Global Medications for Canine Atopic Dermatitis Sales Volume by Region
5.2.1 Global Medications for Canine Atopic Dermatitis Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Medications for Canine Atopic Dermatitis Sales Volume by Region (2019-2024)
5.2.3 Global Medications for Canine Atopic Dermatitis Sales Volume by Region (2025-2030)
5.2.4 Global Medications for Canine Atopic Dermatitis Sales Volume by Region (%), (2019-2030)
5.3 Global Medications for Canine Atopic Dermatitis Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
5.4.2 North America Medications for Canine Atopic Dermatitis Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
5.5.2 Europe Medications for Canine Atopic Dermatitis Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
5.6.2 Asia Pacific Medications for Canine Atopic Dermatitis Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
5.7.2 South America Medications for Canine Atopic Dermatitis Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
5.8.2 Middle East & Africa Medications for Canine Atopic Dermatitis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Value
6.2.1 Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
6.2.2 Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
6.3.2 United States Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Medications for Canine Atopic Dermatitis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
6.4.2 Europe Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Medications for Canine Atopic Dermatitis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
6.5.2 China Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Medications for Canine Atopic Dermatitis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
6.6.2 Japan Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Medications for Canine Atopic Dermatitis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
6.7.2 South Korea Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Medications for Canine Atopic Dermatitis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
6.8.2 Southeast Asia Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Medications for Canine Atopic Dermatitis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Medications for Canine Atopic Dermatitis Sales Value, 2019-2030
6.9.2 India Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Medications for Canine Atopic Dermatitis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GlenHaven
7.1.1 GlenHaven Company Information
7.1.2 GlenHaven Introduction and Business Overview
7.1.3 GlenHaven Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.1.4 GlenHaven Medications for Canine Atopic Dermatitis Product Offerings
7.1.5 GlenHaven Recent Development
7.2 DermaPet
7.2.1 DermaPet Company Information
7.2.2 DermaPet Introduction and Business Overview
7.2.3 DermaPet Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.2.4 DermaPet Medications for Canine Atopic Dermatitis Product Offerings
7.2.5 DermaPet Recent Development
7.3 DVM Pharmaceuticals
7.3.1 DVM Pharmaceuticals Company Information
7.3.2 DVM Pharmaceuticals Introduction and Business Overview
7.3.3 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.3.4 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Product Offerings
7.3.5 DVM Pharmaceuticals Recent Development
7.4 Virbac
7.4.1 Virbac Company Information
7.4.2 Virbac Introduction and Business Overview
7.4.3 Virbac Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Virbac Medications for Canine Atopic Dermatitis Product Offerings
7.4.5 Virbac Recent Development
7.5 Enzo Life Sciences, Inc.
7.5.1 Enzo Life Sciences, Inc. Company Information
7.5.2 Enzo Life Sciences, Inc. Introduction and Business Overview
7.5.3 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Product Offerings
7.5.5 Enzo Life Sciences, Inc. Recent Development
7.6 Pfizer Animal Health
7.6.1 Pfizer Animal Health Company Information
7.6.2 Pfizer Animal Health Introduction and Business Overview
7.6.3 Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Pfizer Animal Health Medications for Canine Atopic Dermatitis Product Offerings
7.6.5 Pfizer Animal Health Recent Development
7.7 Novartis Animal Health, Inc.
7.7.1 Novartis Animal Health, Inc. Company Information
7.7.2 Novartis Animal Health, Inc. Introduction and Business Overview
7.7.3 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Product Offerings
7.7.5 Novartis Animal Health, Inc. Recent Development
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Company Information
7.8.2 Eli Lilly and Company Introduction and Business Overview
7.8.3 Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Eli Lilly and Company Medications for Canine Atopic Dermatitis Product Offerings
7.8.5 Eli Lilly and Company Recent Development
7.9 Perrigo
7.9.1 Perrigo Company Information
7.9.2 Perrigo Introduction and Business Overview
7.9.3 Perrigo Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Perrigo Medications for Canine Atopic Dermatitis Product Offerings
7.9.5 Perrigo Recent Development
7.10 Merck & Company
7.10.1 Merck & Company Company Information
7.10.2 Merck & Company Introduction and Business Overview
7.10.3 Merck & Company Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Merck & Company Medications for Canine Atopic Dermatitis Product Offerings
7.10.5 Merck & Company Recent Development
7.11 Zoetis Inc.
7.11.1 Zoetis Inc. Company Information
7.11.2 Zoetis Inc. Introduction and Business Overview
7.11.3 Zoetis Inc. Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Zoetis Inc. Medications for Canine Atopic Dermatitis Product Offerings
7.11.5 Zoetis Inc. Recent Development
7.12 Toray Industries, Inc
7.12.1 Toray Industries, Inc Company Information
7.12.2 Toray Industries, Inc Introduction and Business Overview
7.12.3 Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Toray Industries, Inc Medications for Canine Atopic Dermatitis Product Offerings
7.12.5 Toray Industries, Inc Recent Development
7.13 Bayer Animal Health
7.13.1 Bayer Animal Health Company Information
7.13.2 Bayer Animal Health Introduction and Business Overview
7.13.3 Bayer Animal Health Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Bayer Animal Health Medications for Canine Atopic Dermatitis Product Offerings
7.13.5 Bayer Animal Health Recent Development
7.14 Putney, Inc.
7.14.1 Putney, Inc. Company Information
7.14.2 Putney, Inc. Introduction and Business Overview
7.14.3 Putney, Inc. Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Putney, Inc. Medications for Canine Atopic Dermatitis Product Offerings
7.14.5 Putney, Inc. Recent Development
7.15 Dechra
7.15.1 Dechra Company Information
7.15.2 Dechra Introduction and Business Overview
7.15.3 Dechra Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Dechra Medications for Canine Atopic Dermatitis Product Offerings
7.15.5 Dechra Recent Development
7.16 Elanco
7.16.1 Elanco Company Information
7.16.2 Elanco Introduction and Business Overview
7.16.3 Elanco Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Elanco Medications for Canine Atopic Dermatitis Product Offerings
7.16.5 Elanco Recent Development
7.17 Kindred Biosciences
7.17.1 Kindred Biosciences Company Information
7.17.2 Kindred Biosciences Introduction and Business Overview
7.17.3 Kindred Biosciences Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Kindred Biosciences Medications for Canine Atopic Dermatitis Product Offerings
7.17.5 Kindred Biosciences Recent Development
7.18 Nippon Zenyaku Kogyo Co., Ltd.
7.18.1 Nippon Zenyaku Kogyo Co., Ltd. Company Information
7.18.2 Nippon Zenyaku Kogyo Co., Ltd. Introduction and Business Overview
7.18.3 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Product Offerings
7.18.5 Nippon Zenyaku Kogyo Co., Ltd. Recent Development
8 Industry Chain Analysis
8.1 Medications for Canine Atopic Dermatitis Industrial Chain
8.2 Medications for Canine Atopic Dermatitis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medications for Canine Atopic Dermatitis Sales Model
8.5.2 Sales Channel
8.5.3 Medications for Canine Atopic Dermatitis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Medications for Canine Atopic Dermatitis Market Trends
    Table 2. Medications for Canine Atopic Dermatitis Market Drivers & Opportunity
    Table 3. Medications for Canine Atopic Dermatitis Market Challenges
    Table 4. Medications for Canine Atopic Dermatitis Market Restraints
    Table 5. Global Medications for Canine Atopic Dermatitis Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Medications for Canine Atopic Dermatitis Revenue Market Share by Company (2019-2024)
    Table 7. Global Medications for Canine Atopic Dermatitis Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Medications for Canine Atopic Dermatitis Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Medications for Canine Atopic Dermatitis Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Medications for Canine Atopic Dermatitis Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Medications for Canine Atopic Dermatitis Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Medications for Canine Atopic Dermatitis
    Table 13. Global Medications for Canine Atopic Dermatitis Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Canine Atopic Dermatitis as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Medications for Canine Atopic Dermatitis Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Medications for Canine Atopic Dermatitis Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Medications for Canine Atopic Dermatitis Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Medications for Canine Atopic Dermatitis Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Medications for Canine Atopic Dermatitis Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Medications for Canine Atopic Dermatitis Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Medications for Canine Atopic Dermatitis Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Medications for Canine Atopic Dermatitis Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Medications for Canine Atopic Dermatitis Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Medications for Canine Atopic Dermatitis Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Medications for Canine Atopic Dermatitis Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Medications for Canine Atopic Dermatitis Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Medications for Canine Atopic Dermatitis Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Medications for Canine Atopic Dermatitis Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Medications for Canine Atopic Dermatitis Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Medications for Canine Atopic Dermatitis Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Medications for Canine Atopic Dermatitis Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Medications for Canine Atopic Dermatitis Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Medications for Canine Atopic Dermatitis Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Medications for Canine Atopic Dermatitis Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Medications for Canine Atopic Dermatitis Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Medications for Canine Atopic Dermatitis Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Medications for Canine Atopic Dermatitis Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Medications for Canine Atopic Dermatitis Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Medications for Canine Atopic Dermatitis Sales Value by Region (2019-2024) & (%)
    Table 44. Global Medications for Canine Atopic Dermatitis Sales Value by Region (2025-2030) & (%)
    Table 45. Global Medications for Canine Atopic Dermatitis Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Medications for Canine Atopic Dermatitis Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Medications for Canine Atopic Dermatitis Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Medications for Canine Atopic Dermatitis Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Medications for Canine Atopic Dermatitis Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Medications for Canine Atopic Dermatitis Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Medications for Canine Atopic Dermatitis Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Volume, (2025-2030) & (K Units)
    Table 57. GlenHaven Company Information
    Table 58. GlenHaven Introduction and Business Overview
    Table 59. GlenHaven Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. GlenHaven Medications for Canine Atopic Dermatitis Product Offerings
    Table 61. GlenHaven Recent Development
    Table 62. DermaPet Company Information
    Table 63. DermaPet Introduction and Business Overview
    Table 64. DermaPet Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. DermaPet Medications for Canine Atopic Dermatitis Product Offerings
    Table 66. DermaPet Recent Development
    Table 67. DVM Pharmaceuticals Company Information
    Table 68. DVM Pharmaceuticals Introduction and Business Overview
    Table 69. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Product Offerings
    Table 71. DVM Pharmaceuticals Recent Development
    Table 72. Virbac Company Information
    Table 73. Virbac Introduction and Business Overview
    Table 74. Virbac Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Virbac Medications for Canine Atopic Dermatitis Product Offerings
    Table 76. Virbac Recent Development
    Table 77. Enzo Life Sciences, Inc. Company Information
    Table 78. Enzo Life Sciences, Inc. Introduction and Business Overview
    Table 79. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Product Offerings
    Table 81. Enzo Life Sciences, Inc. Recent Development
    Table 82. Pfizer Animal Health Company Information
    Table 83. Pfizer Animal Health Introduction and Business Overview
    Table 84. Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Pfizer Animal Health Medications for Canine Atopic Dermatitis Product Offerings
    Table 86. Pfizer Animal Health Recent Development
    Table 87. Novartis Animal Health, Inc. Company Information
    Table 88. Novartis Animal Health, Inc. Introduction and Business Overview
    Table 89. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Product Offerings
    Table 91. Novartis Animal Health, Inc. Recent Development
    Table 92. Eli Lilly and Company Company Information
    Table 93. Eli Lilly and Company Introduction and Business Overview
    Table 94. Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Eli Lilly and Company Medications for Canine Atopic Dermatitis Product Offerings
    Table 96. Eli Lilly and Company Recent Development
    Table 97. Perrigo Company Information
    Table 98. Perrigo Introduction and Business Overview
    Table 99. Perrigo Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Perrigo Medications for Canine Atopic Dermatitis Product Offerings
    Table 101. Perrigo Recent Development
    Table 102. Merck & Company Company Information
    Table 103. Merck & Company Introduction and Business Overview
    Table 104. Merck & Company Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Merck & Company Medications for Canine Atopic Dermatitis Product Offerings
    Table 106. Merck & Company Recent Development
    Table 107. Zoetis Inc. Company Information
    Table 108. Zoetis Inc. Introduction and Business Overview
    Table 109. Zoetis Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Zoetis Inc. Medications for Canine Atopic Dermatitis Product Offerings
    Table 111. Zoetis Inc. Recent Development
    Table 112. Toray Industries, Inc Company Information
    Table 113. Toray Industries, Inc Introduction and Business Overview
    Table 114. Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Toray Industries, Inc Medications for Canine Atopic Dermatitis Product Offerings
    Table 116. Toray Industries, Inc Recent Development
    Table 117. Bayer Animal Health Company Information
    Table 118. Bayer Animal Health Introduction and Business Overview
    Table 119. Bayer Animal Health Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Bayer Animal Health Medications for Canine Atopic Dermatitis Product Offerings
    Table 121. Bayer Animal Health Recent Development
    Table 122. Putney, Inc. Company Information
    Table 123. Putney, Inc. Introduction and Business Overview
    Table 124. Putney, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Putney, Inc. Medications for Canine Atopic Dermatitis Product Offerings
    Table 126. Putney, Inc. Recent Development
    Table 127. Dechra Company Information
    Table 128. Dechra Introduction and Business Overview
    Table 129. Dechra Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Dechra Medications for Canine Atopic Dermatitis Product Offerings
    Table 131. Dechra Recent Development
    Table 132. Elanco Company Information
    Table 133. Elanco Introduction and Business Overview
    Table 134. Elanco Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Elanco Medications for Canine Atopic Dermatitis Product Offerings
    Table 136. Elanco Recent Development
    Table 137. Kindred Biosciences Company Information
    Table 138. Kindred Biosciences Introduction and Business Overview
    Table 139. Kindred Biosciences Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Kindred Biosciences Medications for Canine Atopic Dermatitis Product Offerings
    Table 141. Kindred Biosciences Recent Development
    Table 142. Nippon Zenyaku Kogyo Co., Ltd. Company Information
    Table 143. Nippon Zenyaku Kogyo Co., Ltd. Introduction and Business Overview
    Table 144. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Product Offerings
    Table 146. Nippon Zenyaku Kogyo Co., Ltd. Recent Development
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Medications for Canine Atopic Dermatitis Downstream Customers
    Table 150. Medications for Canine Atopic Dermatitis Distributors List
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Medications for Canine Atopic Dermatitis Product Picture
    Figure 2. Global Medications for Canine Atopic Dermatitis Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Medications for Canine Atopic Dermatitis Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Medications for Canine Atopic Dermatitis Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Medications for Canine Atopic Dermatitis Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Medications for Canine Atopic Dermatitis Report Years Considered
    Figure 7. Global Medications for Canine Atopic Dermatitis Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Medications for Canine Atopic Dermatitis Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Medications for Canine Atopic Dermatitis Revenue in 2023
    Figure 10. Medications for Canine Atopic Dermatitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oral Picture
    Figure 12. External Use Picture
    Figure 13. Injection Picture
    Figure 14. Global Medications for Canine Atopic Dermatitis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Medications for Canine Atopic Dermatitis Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Medications for Canine Atopic Dermatitis Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Medications for Canine Atopic Dermatitis Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Medications for Canine Atopic Dermatitis Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Veterinary Hospital
    Figure 20. Product Picture of Veterinary Clinic
    Figure 21. Global Medications for Canine Atopic Dermatitis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Medications for Canine Atopic Dermatitis Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Medications for Canine Atopic Dermatitis Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Medications for Canine Atopic Dermatitis Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Medications for Canine Atopic Dermatitis Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Medications for Canine Atopic Dermatitis Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Medications for Canine Atopic Dermatitis Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Medications for Canine Atopic Dermatitis Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Medications for Canine Atopic Dermatitis Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Medications for Canine Atopic Dermatitis Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Medications for Canine Atopic Dermatitis Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Medications for Canine Atopic Dermatitis Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Medications for Canine Atopic Dermatitis Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Medications for Canine Atopic Dermatitis Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Medications for Canine Atopic Dermatitis Sales Volume (%), (2019-2030)
    Figure 38. United States Medications for Canine Atopic Dermatitis Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Medications for Canine Atopic Dermatitis Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Medications for Canine Atopic Dermatitis Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Medications for Canine Atopic Dermatitis Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Medications for Canine Atopic Dermatitis Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Medications for Canine Atopic Dermatitis Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Medications for Canine Atopic Dermatitis Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Medications for Canine Atopic Dermatitis Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Medications for Canine Atopic Dermatitis Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Medications for Canine Atopic Dermatitis Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Medications for Canine Atopic Dermatitis Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Medications for Canine Atopic Dermatitis Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Medications for Canine Atopic Dermatitis Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Medications for Canine Atopic Dermatitis Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Medications for Canine Atopic Dermatitis Sales Value by Application (%), 2023 VS 2030
    Figure 59. Medications for Canine Atopic Dermatitis Industrial Chain
    Figure 60. Medications for Canine Atopic Dermatitis Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS